Throughout our iGEM journey, our team has been dedicated to addressing critical challenges in infant nutrition. In doing so, we have not only developed innovative biological systems but also generated a wealth of knowledge and resources that we believe will be invaluable to future iGEM teams. Our contributions are multifaceted, spanning from the creation and detailed characterization of new BioBrick parts to the development of practical guides for experimental procedures, human practices, and scientific communication.
We have consolidated our experiences into a series of comprehensive documents and new data for the Parts Registry. These resources are designed to help future teams navigate similar challenges, avoid potential pitfalls, and build upon our work. Our contributions encompass four key areas: a collection of robustly characterized biological parts, insights from our research process, a detailed experimental manual, and effective strategies for event organization and outreach. We hope these efforts will empower future iGEMers to accelerate their projects and make an even greater impact.
The Bronze part we contributed to is
While the sequence for BBa_I732005 exists in the registry, its documentation lacks a complete, quantitative "gene-to-function" validation pipeline. We have filled this gap by performing a systematic, three-step characterization process, providing future iGEM teams with robust data and a clear protocol for expressing and validating a functional lactase enzyme.
We performed a full workflow to validate this part, from initial gene cloning to final enzymatic activity quantification.
To express the enzyme, we first cloned the codon-optimized lacZ gene (from BBa_I732005) into a pET-28a expression vector. The successful construction of the pET-28a-lacZ plasmid was confirmed by agarose gel electrophoresis following restriction digestion. As shown in Figure 1, a distinct band was observed at the expected size of
Figure 1: Construction of BL21-LacZ. (A) The plasmid map of pET28a-LacZ; (B) The gene circuit of BL21-LacZ; (C) The flow chart of "Construction of BL21-LacZ"; (D) the agarose gel electrophoresis analysis of the lacZ gene fragment
Next, we confirmed the expression of the protein product. The pET-28a-lacZ plasmid was transformed into E. coli BL21(DE3), and protein expression was induced. Cell lysates were analyzed using SDS-PAGE and Western Blot. The Western Blot analysis (Figure 2), using an anti-His antibody, detected a single, prominent band at the expected molecular weight of
Figure 2: (A) This is a flow chart of Western Blot; (B) SDS-PAGE analysis of recombinant lacZ overexpression in E. coli
The final and most critical step was to quantify the enzyme's catalytic activity. The expressed β-galactosidase was purified and added to a 10 mM lactose reaction system. The degradation of lactose was monitored over an 8-hour period by measuring the production of glucose using a glucose assay kit. The results (Figure 3) clearly demonstrate that the enzyme is highly active. The initial lactose concentration of 10 mM was steadily reduced to approximately
Figure 3: (A)This is a flow chart of measurement of the lactose content lacZ breaks down; (B) Efficacy of recombinant β-galactosidase in lactose degradation
By providing this comprehensive, quantitative characterization, we have significantly enhanced the value and reliability of
This complete dataset transforms BBa_I732005 from a simple coding sequence into a well-documented, functionally validated tool, ready for use in projects requiring lactose hydrolysis, such as the production of lactose-free dairy products, biosensor development, or metabolic engineering applications.
To ensure the reproducibility of our work, we are providing future teams with our detailed, step-by-step protocols for protein expression, purification, and the functional activity assay on our wiki's Experiments page.
Effective communication is paramount in conveying the complexity and innovation of a synthetic biology project. Recognizing this, our team placed a strong emphasis on creating clear, professional, and impactful scientific illustrations. We utilized BioRender to design crucial project visuals, from intricate pathway flowcharts to the final results figures.
Through this process, we gained extensive hands-on experience and identified a need for a consolidated resource to help other researchers master this powerful tool. To contribute to the iGEM community and beyond, we have channeled our expertise into producing
This manual is more than just a summary of our work; it is a step-by-step guide designed to flatten the learning curve for new users while offering valuable tips for seasoned illustrators. It covers everything from the foundational interface and workflow procedures to advanced features like collaborative editing, creating publication-quality graphics, and even importing protein structures directly from the PDB. Our goal is to equip future iGEM teams with the skills to elevate their scientific storytelling, ensuring their hard work is presented with the clarity and professionalism it deserves.
Document 1: BioRender User Guidance(Due to upload restrictions, we have divided the file into three parts.)
To prevent future teams from encountering the same obstacles we faced, we have compiled a detailed
Furthermore, our team has dedicated significant effort to creating clear and professional scientific illustrations. We have compiled our experiences and tips into a
Figures 4: Experimental Manual
Figures 5: Team members conducting interview in park
Effective communication and organization are key to a successful Human Practices component. Based on our experience conducting interviews and educational events, we have summarized several key strategies:
Figure 6:Event organization tips
Source research experience
Gathering credible information is the foundation of any successful scientific project. We learned that a thorough and systematic approach is crucial. For future teams, we recommend the following:
Figure 7: A guide to identifying credible and non-credible sources